Eat to fast: Valter Longo's FMD protocol, IGF-1 reduction, and what 5 days can do to your biology

What the Fasting Mimicking Diet is — and why it isn't simply calorie restriction

Most people assume the body only enters a fasting state when food is completely withheld. Dr. Valter Longo's lab at the USC Longevity Institute spent more than a decade mapping what actually triggers the molecular machinery of fasting — reduced mTOR signaling, suppressed IGF-1 production, upregulated AMPK — and found that specific macro ratios at very low calorie loads can fool those pathways into behaving as if you haven't eaten at all.

The Fasting Mimicking Diet is the result: a 5-day protocol delivering 800–1,100 kcal per day from plant-based, low-protein, low-glycemic sources arranged to keep protein below 10% of total calories, carbohydrate from non-starchy sources only, and fat providing roughly 44% of intake from nuts and olive oil. The nutrient composition is precise; the mechanism depends on the ratio, not merely the total calorie number.

This distinction matters practically. Complete fasting for 5 days is adherence-prohibitive for most people, carries risks of lean mass loss, and cannot be performed monthly without medical supervision. FMD threads a narrower path: enough food to remain functional, precise enough composition to preserve the fasting signal.

IGF-1 suppression and autophagy: the two primary longevity signals

Insulin-like Growth Factor 1 (IGF-1) is a hormone produced primarily in the liver in response to growth hormone and dietary protein. In the context of longevity biology, chronically elevated IGF-1 is correlated with accelerated aging and elevated cancer risk — the pathway promotes cell growth and division, which in an environment of cellular damage or DNA errors, becomes a liability rather than an asset.

Lower IGF-1 is one of the most consistent features of long-lived organisms, from dwarf mice to centenarian human populations with Laron syndrome. Caloric restriction and protein restriction are the two dietary levers with the strongest human evidence for sustained IGF-1 reduction.

The FMD produces rapid, large IGF-1 drops during its 5 days. In the pivotal Brandhorst et al. (2015) Cell Metabolism human trial, three monthly FMD cycles in 71 participants produced average IGF-1 reductions of approximately 24%. Participants with the highest baseline IGF-1 — generally those consuming the most dietary protein — showed the sharpest drops.

Autophagy — the cellular process by which damaged organelles, misfolded proteins, and dysfunctional mitochondria are broken down and recycled — requires a period of nutrient withdrawal to upregulate. mTORC1, which acts as the cellular "growth switch," must be suppressed for autophagy to proceed. The low-protein, low-carbohydrate nature of FMD suppresses both mTORC1 activity and insulin secretion, creating the same signaling environment as fasting for autophagy induction. The Nobelist Yoshinori Ohsumi's foundational work on autophagy and subsequent research from the Longo lab have mapped this pathway in molecular detail.

Clinical trial evidence: what the studies actually measured

The FMD research base is unusual for a dietary intervention in that it includes both animal mechanistic data and human randomized trials. The table below summarizes key studies by population, IGF-1 effect, and primary outcome.

The oncology data warrants specific attention. The hypothesis behind FMD in cancer contexts is not fringe: calorie restriction has been shown to enhance chemotherapy efficacy in animal models since the 1980s, and the Caffa/Longo JAMA Oncology data from the DigesT trial represents the first large Phase II human trial to quantify this in hormone-receptor-positive breast cancer. The mechanism is partly IGF-1-mediated — cancer cells that are constitutively IGF-1 dependent are preferentially stressed by its withdrawal.

The multiple sclerosis finding: remyelination and immune reset

The 2016 Choi et al. study in Cell Reports introduced a finding that most longevity coverage has underweighted: periodic FMD cycles in mouse models of multiple sclerosis did not merely slow disease progression — they promoted measurable remyelination and partial restoration of motor function.

The proposed mechanism involves FMD-induced depletion of pro-inflammatory immune cells followed by rebound regeneration from hematopoietic stem cells during the refeeding phase. This "immune system reset" hypothesis had previously been demonstrated in the context of chemotherapy-induced immunosuppression — the Longo lab showed that fasting before chemotherapy protected normal cells while sensitizing cancer cells, and the post-fast rebound produced regenerated white blood cells from stem cells rather than simply recovering the damaged population.

Applied to autoimmune disease, the hypothesis is that periodic depletion of autoreactive immune cells during FMD, followed by stem-cell-driven immune regeneration in refeeding, could break the self-attack cycle. In the mouse relapsing-remitting MS model, FMD cycles combined with refeeding produced oligodendrocyte regeneration and structural remyelination on electron microscopy — not just symptom suppression.

The 60-participant human pilot that accompanied this paper was small and unblinded, but quality-of-life scores, self-reported fatigue, and depression measures all improved in the FMD group. A larger randomized trial (NCT04009174) is ongoing at the University of Münster. This is not yet a clinical treatment — it is a scientifically serious hypothesis with promising early human data.

ProLon vs. DIY: what the kit provides and what you can replicate

ProLon is the commercially licensed FMD kit developed by L-Nutra under Valter Longo's guidance and used in the clinical trials. It ships pre-portioned food for all 5 days — vegetable soups, nut bars, crackers, supplements, and herbal teas — calibrated to the exact macro ratios validated in the research. The convenience is real; the macro precision eliminates the most common adherence failure (calorie or protein creep). It typically costs $180–$250 per 5-day box depending on subscription.

DIY FMD is achievable using the published macro framework: Day 1 at approximately 1,100 kcal; Days 2–5 at 800 kcal. Protein must stay below 10% of calories — roughly 20–25g per day maximum. Carbohydrate from low-glycemic sources only (no grains, no legumes with high glycemic load). Fat from olives, olive oil, and nuts. A rough food list: vegetable broth-based soups, kalamata olives, walnuts, macadamia nuts, herbal teas, cucumber, celery, tomato in small amounts. Food tracking is non-negotiable; protein overages are the most common protocol break.

The clinical evidence was generated with ProLon. DIY protocols that match the macros should produce comparable outcomes, but have not been independently validated in RCTs. For a first cycle, ProLon removes variables and ensures you complete the 5 days with the correct biology.

Monthly cycling: why frequency matters for longevity outcomes

A single 5-day FMD cycle produces measurable biological changes — IGF-1 drops, ketone elevation, autophagy markers rise. Most of those changes begin reversing within 2–5 days of refeeding as the body restores homeostasis. The longevity hypothesis depends on what accumulates across cycles: stem cell regeneration events, epigenetic remodeling, and sustained improvements in metabolic markers that don't fully regress between cycles.

The Brandhorst 2015 trial ran three monthly cycles and measured outcomes before, between, and after. The most significant metabolic improvements — particularly in IGF-1, fasting glucose, and abdominal fat — accumulated across the three cycles. Individuals who completed all three showed substantially better results than those who completed only one or two. This is consistent with the hypothesis that the refeeding phase is not a return to baseline but a regenerative event — the body rebuilds from a slightly cleaner starting point each time.

Longo's publicly stated recommendation, based on this data, is monthly FMD cycles for individuals with metabolic risk factors (elevated fasting glucose, BMI above 25, high CRP, elevated IGF-1). For otherwise healthy adults with no metabolic risk markers, he suggests once every 3–6 months as a maintenance protocol. The goal is periodic biological "reset," not chronic calorie restriction — normal eating between cycles is both expected and required for the stem cell regeneration mechanism to work properly.